878735

Bell International Laboratories, Inc. — FEI 3005574978

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
May 14, 2014
Fiscal Year
2014
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Eagan, MN (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)